655 filings
DEF 14A
SRPT
Sarepta Therapeutics Inc
Definitive proxy
24 Apr 24
4:05pm
ARS
2023 FY
SRPT
Sarepta Therapeutics Inc
24 Apr 24
Annual report to shareholders
4:02pm
DEFA14A
SRPT
Sarepta Therapeutics Inc
24 Apr 24
Additional proxy soliciting materials
4:01pm
S-8 POS
SRPT
Sarepta Therapeutics Inc
28 Mar 24
Registration of securities for employees (post-effective amendment)
4:16pm
S-8 POS
SRPT
Sarepta Therapeutics Inc
28 Mar 24
Registration of securities for employees (post-effective amendment)
4:15pm
S-8 POS
onyfku555 q6pzkimc2w
28 Mar 24
Registration of securities for employees (post-effective amendment)
4:14pm
S-8 POS
f9k53rvs
28 Mar 24
Registration of securities for employees (post-effective amendment)
4:12pm
8-K
6miedn6wex z80l6kw
8 Jan 24
Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2023 Net Product Revenue
12:08pm
S-8
c7kshv
2 Aug 23
Registration of securities for employees
4:19pm
8-K
t7oe8wzu3wrvq3y
22 Jun 23
Regulation FD Disclosure
4:49pm
8-K
nn6okotvo4fv0s2rec2l
22 Jun 23
Sarepta Therapeutics Announces FDA Approval of ELEVIDYS, the First Gene Therapy to Treat Duchenne Muscular Dystrophy
12:00am
8-K
cusody2 ssv6ygjoy
9 Jun 23
Departure of Directors or Certain Officers
4:29pm
DEFA14A
73o14jya2g
24 Apr 23
Additional proxy soliciting materials
4:16pm
ARS
tj5 fyc3ocfwdler9vpl
24 Apr 23
Annual report to shareholders
4:10pm
8-K
hli6a2pghhx 623za
3 Mar 23
Entry into a Material Definitive Agreement
7:31am